• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于电子健康记录数据的神经危重症护理绩效指标是可行的,并揭示了特定站点的差异:一项 CHoRUS 试点项目。

Neurocritical Care Performance Measures Derived from Electronic Health Record Data are Feasible and Reveal Site-Specific Variation: A CHoRUS Pilot Project.

机构信息

Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Department of Neurology, New York-Presbyterian Hospital, New York, NY, USA.

出版信息

Neurocrit Care. 2022 Aug;37(Suppl 2):276-290. doi: 10.1007/s12028-022-01497-0. Epub 2022 Jun 10.

DOI:10.1007/s12028-022-01497-0
PMID:35689135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10327405/
Abstract

BACKGROUND

We evaluated the feasibility and discriminability of recently proposed Clinical Performance Measures for Neurocritical Care (Neurocritical Care Society) and Quality Indicators for Traumatic Brain Injury (Collaborative European NeuroTrauma Effectiveness Research in TBI; CENTER-TBI) extracted from electronic health record (EHR) flowsheet data.

METHODS

At three centers within the Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI consortium, we examined consecutive neurocritical care admissions exceeding 24 h (03/2015-02/2020) and evaluated the feasibility, discriminability, and site-specific variation of five clinical performance measures and quality indicators: (1) intracranial pressure (ICP) monitoring (ICPM) within 24 h when indicated, (2) ICPM latency when initiated within 24 h, (3) frequency of nurse-documented neurologic assessments, (4) intermittent pneumatic compression device (IPCd) initiation within 24 h, and (5) latency to IPCd application. We additionally explored associations between delayed IPCd initiation and codes for venous thromboembolism documented using the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) system. Median (interquartile range) statistics are reported. Kruskal-Wallis tests were measured for differences across centers, and Dunn statistics were reported for between-center differences.

RESULTS

A total of 14,985 admissions met inclusion criteria. ICPM was documented in 1514 (10.1%), neurologic assessments in 14,635 (91.1%), and IPCd application in 14,175 (88.5%). ICPM began within 24 h for 1267 (83.7%), with site-specific latency differences among sites 1-3, respectively, (0.54 h [2.82], 0.58 h [1.68], and 2.36 h [4.60]; p < 0.001). The frequency of nurse-documented neurologic assessments also varied by site (17.4 per day [5.97], 8.4 per day [3.12], and 15.3 per day [8.34]; p < 0.001) and diurnally (6.90 per day during daytime hours vs. 5.67 per day at night, p < 0.001). IPCds were applied within 24 h for 12,863 (90.7%) patients meeting clinical eligibility (excluding those with EHR documentation of limiting injuries, actively documented as ambulating, or refusing prophylaxis). In-hospital venous thromboembolism varied by site (1.23%, 1.55%, and 5.18%; p < 0.001) and was associated with increased IPCd latency (overall, 1.02 h [10.4] vs. 0.97 h [5.98], p = 0.479; site 1, 2.25 h [10.27] vs. 1.82 h [7.39], p = 0.713; site 2, 1.38 h [5.90] vs. 0.80 h [0.53], p = 0.216; site 3, 0.40 h [16.3] vs. 0.35 h [11.5], p = 0.036).

CONCLUSIONS

Electronic health record-derived reporting of neurocritical care performance measures is feasible and demonstrates site-specific variation. Future efforts should examine whether performance or documentation drives these measures, what outcomes are associated with performance, and whether EHR-derived measures of performance measures and quality indicators are modifiable.

摘要

背景

我们评估了最近提出的神经重症监护临床绩效指标(神经重症监护学会)和创伤性脑损伤质量指标(欧洲合作神经创伤效应研究创伤性脑损伤;CENTER-TBI)从电子健康记录(EHR)流程表数据中提取的可行性和可区分性。

方法

在合作医院存储库统一标准(CHoRUS)的三个中心内,我们检查了连续超过 24 小时的神经重症监护入院病例(2015 年 3 月至 2020 年 2 月),并评估了五项临床绩效指标和质量指标的可行性、可区分性和特定于站点的变化:(1)当需要时在 24 小时内进行颅内压(ICP)监测(ICP 监测),(2)在 24 小时内开始 ICP 监测时的潜伏期,(3)护士记录的神经评估频率,(4)在 24 小时内开始间歇性气动压缩装置(IPC),以及(5)IPC 应用的潜伏期。我们还探索了延迟开始 IPC 与使用国际疾病和相关健康问题第十次修订版(ICD-10)系统记录的静脉血栓栓塞症代码之间的关联。报告中位数(四分位距)统计数据。使用 Kruskal-Wallis 检验测量中心之间的差异,并用 Dunn 统计报告中心之间的差异。

结果

共有 14985 例入院符合纳入标准。1514 例(10.1%)记录了 ICPM,14635 例(91.1%)记录了神经评估,14175 例(88.5%)记录了 IPC 应用。1267 例(83.7%)在 24 小时内开始 ICPM,站点 1-3 的潜伏期差异具有统计学意义,分别为 0.54 小时(2.82)、0.58 小时(1.68)和 2.36 小时(4.60)(p < 0.001)。护士记录的神经评估频率也因站点而异(17.4 次/天[5.97]、8.4 次/天[3.12]和 15.3 次/天[8.34];p < 0.001)和昼夜差异(白天 6.90 次/天与夜间 5.67 次/天,p < 0.001)。符合临床资格的 12863 例(90.7%)患者在 24 小时内接受了 IPC,排除了 EHR 记录有局限性损伤、被明确记录为可活动或拒绝预防的患者。院内静脉血栓栓塞的发生率因站点而异(1.23%、1.55%和 5.18%;p < 0.001),与 IPC 潜伏期延长有关(总体而言,1.02 小时[10.4]与 0.97 小时[5.98],p = 0.479;站点 1,2.25 小时[10.27]与 1.82 小时[7.39],p = 0.713;站点 2,1.38 小时[5.90]与 0.80 小时[0.53],p = 0.216;站点 3,0.40 小时[16.3]与 0.35 小时[11.5],p = 0.036)。

结论

从电子健康记录中提取神经重症监护绩效指标的报告是可行的,并且表现出特定于站点的变化。未来的研究应探讨是绩效还是文件记录推动了这些指标,哪些结果与绩效相关,以及电子健康记录中提取的绩效指标和质量指标是否可以修改。

相似文献

1
Neurocritical Care Performance Measures Derived from Electronic Health Record Data are Feasible and Reveal Site-Specific Variation: A CHoRUS Pilot Project.基于电子健康记录数据的神经危重症护理绩效指标是可行的,并揭示了特定站点的差异:一项 CHoRUS 试点项目。
Neurocrit Care. 2022 Aug;37(Suppl 2):276-290. doi: 10.1007/s12028-022-01497-0. Epub 2022 Jun 10.
2
A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study.一种用于预防静脉血栓形成和出血风险均最高的骨科患者静脉血栓栓塞的便携式气动压缩装置:一项病例系列研究。
J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(1):2309499020905711. doi: 10.1177/2309499020905711.
3
Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review.间歇性气动压迫装置对高危手术患者预防静脉血栓栓塞的有效性:一项系统评价
J Arthroplasty. 2016 Feb;31(2):524-32. doi: 10.1016/j.arth.2015.09.043. Epub 2015 Oct 29.
4
Clinical Experience With a Dedicated Neurocritical Care Quality Improvement Program in an Academic Medical Center.学术医疗中心中一个专门的神经重症监护质量改进项目的临床经验。
Cureus. 2024 Jan 22;16(1):e52730. doi: 10.7759/cureus.52730. eCollection 2024 Jan.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
A Propensity Score Analysis of the Impact of Invasive Intracranial Pressure Monitoring on Outcomes after Severe Traumatic Brain Injury.有创颅内压监测对重度创伤性脑损伤后结局影响的倾向评分分析
J Neurotrauma. 2016 May 1;33(9):853-8. doi: 10.1089/neu.2015.4015. Epub 2015 Oct 8.
7
Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT.颅脑创伤后降低颅内压的治疗性低温:Eurotherm3235 RCT 研究。
Health Technol Assess. 2018 Aug;22(45):1-134. doi: 10.3310/hta22450.
8
Risk Adjustment In Neurocritical care (RAIN)--prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study.神经重症监护中的风险调整(RAIN)——前瞻性验证用于评估神经重症监护最佳位置和比较成本的成人急性创伤性脑损伤风险预测模型:一项队列研究。
Health Technol Assess. 2013 Jun;17(23):vii-viii, 1-350. doi: 10.3310/hta17230.
9
Using Electronic Clinical Quality Measures (eCQMs) to Perform a Venous Thromboembolism Prophylaxis Rapid Cycle Quality Improvement Initiative.使用电子临床质量指标(eCQMs)开展静脉血栓栓塞预防快速循环质量改进计划。
Jt Comm J Qual Patient Saf. 2019 Nov;45(11):750-756. doi: 10.1016/j.jcjq.2019.07.011. Epub 2019 Aug 30.
10
The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.术中间歇性气动压迫装置在全髋关节置换术和全膝关节置换术中预防静脉血栓栓塞的作用
Orthopedics. 2018 Jan 1;41(1):e98-e103. doi: 10.3928/01477447-20171114-06. Epub 2017 Nov 21.

引用本文的文献

1
Social Determinants of Health and Limitation of Life-Sustaining Therapy in Neurocritical Care: A CHoRUS Pilot Project.神经危重症监护中的健康社会决定因素和生命维持治疗的限制:一项 CHoRUS 试点项目。
Neurocrit Care. 2024 Dec;41(3):866-879. doi: 10.1007/s12028-024-02007-0. Epub 2024 Jun 6.
2
Practice-Pattern Variation in Sedation of Neurotrauma Patients in the Intensive Care Unit: An International Survey.神经创伤患者在重症监护病房镇静的实践模式差异:一项国际调查。
J Intensive Care Med. 2023 Dec;38(12):1143-1150. doi: 10.1177/08850666231186563. Epub 2023 Jul 7.

本文引用的文献

1
A Locally Optimized Data-Driven Tool to Predict Sepsis-Associated Vasopressor Use in the ICU.一种局部优化的数据驱动工具,用于预测 ICU 中与败血症相关的血管加压药使用。
Crit Care Med. 2021 Dec 1;49(12):e1196-e1205. doi: 10.1097/CCM.0000000000005175.
2
Generalization in Clinical Prediction Models: The Blessing and Curse of Measurement Indicator Variables.临床预测模型中的泛化:测量指标变量的幸与不幸
Crit Care Explor. 2021 Jun 25;3(7):e0453. doi: 10.1097/CCE.0000000000000453. eCollection 2021 Jul.
3
International Practice Variability in Treatment of Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血治疗的国际实践差异
J Clin Med. 2021 Feb 14;10(4):762. doi: 10.3390/jcm10040762.
4
Quality indicators for patients with traumatic brain injury in European intensive care units: a CENTER-TBI study.欧洲重症监护病房创伤性脑损伤患者的质量指标:CENTER-TBI 研究。
Crit Care. 2020 Mar 4;24(1):78. doi: 10.1186/s13054-020-2791-0.
5
Quality improvement in neurocritical care: current state and looking to the future.神经危重症护理质量改进:现状与展望。
Curr Opin Crit Care. 2020 Apr;26(2):97-102. doi: 10.1097/MCC.0000000000000714.
6
Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society.神经危重症临床绩效评估指标:神经重症监护学会医疗专业人员立场声明。
Neurocrit Care. 2020 Feb;32(1):5-79. doi: 10.1007/s12028-019-00846-w.
7
Development of a quality indicator set to measure and improve quality of ICU care for patients with traumatic brain injury.开发一套质量指标集,以衡量和改善创伤性脑损伤患者 ICU 护理质量。
Crit Care. 2019 Mar 22;23(1):95. doi: 10.1186/s13054-019-2377-x.
8
Participation in Get With The Guidelines-Stroke and Its Association With Quality of Care for Stroke.参与 Get With The Guidelines-Stroke 及其与卒中护理质量的关系。
JAMA Neurol. 2018 Nov 1;75(11):1331-1337. doi: 10.1001/jamaneurol.2018.2101.
9
Development and Validation of Electronic Quality Measures to Assess Care for Patients With Transient Ischemic Attack and Minor Ischemic Stroke.用于评估短暂性脑缺血发作和轻度缺血性卒中患者护理的电子质量指标的开发与验证
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.116.003157.
10
Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.为什么急性缺血性中风患者未接受静脉注射组织型纤溶酶原激活剂(IV tPA)?一项全国性登记研究的结果。
Neurology. 2016 Oct 11;87(15):1565-1574. doi: 10.1212/WNL.0000000000003198. Epub 2016 Sep 14.